Het boemerang effect. ????? pic.twitter.com/g1buNTpX8W
— Sam (@Sam03182560) May 9, 2021
2. News story about a man being shot in the departure terminal of Vancouver Airport. That is ALL the information provided. Welcome to the Winston Smith Newsroom.
3. Rebel News video on Alberta’s various arrests of people who decided to live free and encourage others to do so as well.
ABC News gets marks for reporting this story when so many similar stories are covered up. For example we are still wating for proof of life of that nurse back at the start of the injections, that passed out right after getting the shot on camera, even though given the massive number of deaths and serious effects of this technology, what happened to that one person only matters in terms of the extent to which vaccine companies are controlling what we can know. But ABC looses marks for not telling us which vaccine clearly caused this mess. The only practical response is don’t get any of them till we know what they do.
Europe’s drug regulator says it’s evaluating an assortment of potential side effects following inoculation with leading COVID-19 vaccines, including heart inflammation, facial swelling and a rare nerve-degenerating disorder. Yet in most circumstances, it’s not clear whether the vaccines are to blame.
In AstraZeneca’s case, the European Medicines Agency’s safety committee, known as PRAC for short, said it’s examining reports of Guillain-Barre syndrome (GBS) among people who received the drugmaker’s COVID-19 vaccine, according to a report released on Friday. The agency is tracking the data for all coronavirus shots as part of its routine safety procedures.
GBS syndrome is a rare disorder that causes nerve inflammation and can result in pain, numbness, muscle weakness and difficulty walking. GBS was previously identified by regulators as a potential adverse side effect that required monitoring following AstraZeneca’s jab, the EMA said. The regulator asked AstraZeneca to provide more detailed data and an analysis of all reported GBS cases for its next safety report, which are required on a monthly basis.
Concerns of rare but serious blood clots among AstraZeneca vaccine recipients have beset Europe’s vaccine rollout for months. In early April, the EMA said the unusual blood clots with low blood platelets should be listed as very rare side effect for the company’s vaccine, marketed as Vaxzevria.
Thank you EB., Richard, PC., Tania Groth, Yucki, Johnny U., ET., EW., and MANY more who have been sending in materials that contribute to genuinely informed choices. The essence of freedom. And those that send in truths either for or against the prevailing winds are doing more for freedom than our elected representatives are doing against it, until those reps close all means of peer to peer communication.
And that’s coming this week in Canada.